VYGR logo

VYGR

Voyager Therapeutics Inc.

$3.36
-$0.04(-1.18%)
44
Overall
--
Value
45
Tech
44
Quality
Market Cap
$189.70M
Volume
203.26K
52W Range
$2.65 - $8.28
Target Price
$15.08
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$17.3M$14.2M$10.1M$7.6M$104.4M$171.1M$37.4M$40.9M$250.0M$80.0M
Total Revenue
$17.3M$14.2M$10.1M$7.6M$104.4M$171.1M$37.4M$40.9M$250.0M$80.0M
GROSS PROFIT
Gross Profit
$17.3M$14.2M$10.1M$7.6M$104.4M$171.1M$37.4M$40.9M$250.0M$80.0M
OPERATING EXPENSES
Operating Expenses
$-37.6M$-55.5M$-82.0M$-98.7M$156.1M$143.7M$111.0M$91.7M$128.0M$163.3M
Research & Development
$27.7M$42.2M$62.3M$64.9M$119.7M$108.8M$73.8M$60.8M$92.2M$127.4M
Research Expense
$27.7M$42.2M$62.3M$64.9M$119.7M$108.8M$73.8M$60.8M$92.2M$127.4M
Selling, General & Administrative
$9.9M$13.3M$19.7M$33.8M$36.3M$35.0M$37.2M$31.0M$35.8M$35.9M
General & Administrative Expenses
$9.9M$13.3M$19.7M$33.8M$36.3M$35.0M$37.2M$31.0M$35.8M$35.9M
Salaries & Wages
$-4.0M$-6.3M$-9.2M$-15.7M------$9.3M$11.2M$14.8M
Depreciation & Amortization
$-600.0K$-612.0K$-1.6M$-2.1M$2.8M$3.8M$5.2M$6.2M$4.4M$4.7M
Depreciation & Amortization
$-600.0K$-612.0K$-1.6M$-2.1M$2.8M$3.8M$5.2M$6.2M$4.4M$4.7M
Other Operating Expenses
$-37.6M$-55.5M$-82.0M$-98.7M$5.7M$6.2M$6.8M$4.6M$3.6M$10.0M
OPERATING INCOME
Operating income
$-20.3M$-41.3M$-71.9M$-91.1M$-51.7M$27.4M$-73.6M$-50.8M$122.0M$-83.3M
EBITDA
$-28.6M$-38.8M$-69.1M$-88.5M$-44.4M$31.2M$-68.5M$-40.2M$138.1M$-59.6M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$9.8M------------------
Intinc
$332.0K$976.0K$1.2M$3.3M$6.5M$1.7M$-390.0K$1.8M$11.7M$18.3M
Net Non-Operating Interest Income/Expense
$332.0K$976.0K$1.2M$3.3M$6.5M$1.7M$-390.0K$1.8M$11.7M$18.3M
Gain on Sale of Securities
$251.0K$66.0K$158.0K--------------
Other Income/Expense
$9.8M$-182.0K$62.0K$683.0K$-1.6M$-7.7M$-2.8M$2.7M$-3.0K$-622.0K
Other Special Charges
$-9.8M$182.0K$-62.0K$-683.0K$1.6M$7.7M$2.8M$2.7M$3.0K$622.0K
SPECIAL ITEMS
Restructring And Mn A Income
------------$2.6M------
Special Income Charges
------------$-2.6M------
Other Impairment Of Capital Assets
------------------$2.8M
PRE-TAX INCOME
EBIT
$-29.7M$-40.1M$-70.7M$-88.5M$-43.6M$27.4M$-73.6M$-46.4M$133.7M$-64.3M
Pre-Tax Income
$-29.7M$-40.1M$-70.7M$-88.5M$-43.6M$36.7M$-71.2M$-46.4M$133.7M$-64.3M
INCOME TAX
Tax Provision
--$52.0K--$-180.0K------$16.0K$1.4M$665.0K
NET INCOME
Net Income
$-29.7M$-40.2M$-70.7M$-88.3M$-43.6M$36.7M$-71.2M$-46.4M$132.3M$-65.0M
Net Income (Continuing Operations)
$-29.7M$-40.2M$-70.7M$-88.3M$-43.6M$36.7M$-71.2M$-46.4M$132.3M$-65.0M
Net Income (Discontinued Operations)
$-29.7M$-40.2M$-70.7M$-88.3M$-43.6M$36.7M$-71.2M$-46.4M$132.3M$-65.0M
Net Income (Common Stockholders)
$-38.3M$-40.2M$-70.7M$-88.3M$-43.6M$36.7M$-71.2M$-46.4M$132.3M$-65.0M
Normalized Income
------------------$-60.9M
TOTALS
Total Expenses
$-37.6M$-55.5M$-82.0M$-98.7M$156.1M$143.7M$111.0M$91.7M$128.0M$163.3M
SHARE & EPS DATA
Average Shares Outstanding
$4.2M$25.3M$26.8M$32.1M$35.9M$37.1M$37.7M$38.4M$43.0M$57.7M
Average Shares Outstanding (Diluted)
$3.2M$25.3M$26.8M$32.1M--$37.3M$37.7M$38.4M$44.6M$57.7M
Shares Outstanding
$26.7M$26.8M$32.2M$32.6M$37.2M$37.7M$38.1M$43.3M$54.3M$55.2M
Basic EPS
--------$-1.21$0.99$-1.89$-1.21$3.08$-1.13
Basic EPS (Continuing Operations)
--------$-1.21$0.99$-1.89$-1.21$3.08$-1.13
Diluted EPS
$-9.14$1.59$-2.64$-2.75$-1.21$0.98$-1.89$-1.21$2.97$-1.13
Diluted EPS (Continuing Operations)
----------$0.98$-1.89$-1.21$2.97$-1.13
OTHER METRICS
Accretion On Preferred Stock
$7.4M------------------
Accrued Preferred Stock Dividends
$1.2M------------------
Gain On Sale Of P P E
--------------$2.5M----
Other Gand A
$9.9M$13.3M$19.7M$33.8M$36.3M$35.0M$37.2M$31.0M$35.8M$35.9M
Otherunder Preferred Stock Dividend
$8.6M------------------
Preferred Stock Dividends
$8.6M------------------
Rent And Landing Fees
$9.9M$13.3M$19.7M$33.8M------------
Restruct
------------$2.6M------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2VYGR$3.36-1.2%203.26K
3
4
5
6

Get Voyager Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.